Serotonin 5-HT1D Receptor Antagonists
DBCAT005167Pharmacologic class
Entities that are capable of exerting an antagonistic effect on 5-HT1D receptors. A DrugBank category of 9 drugs. 6 of them are approved.
What you can answer from here — as of July 02, 2020
Which targets do Serotonin 5-HT1D Receptor Antagonists share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account